Masco Group acquires KeyPlants AB, a leading global provider of modular Life Science facilities
Masco Group, global provider of technological solutions for the pharmaceutical and biotech industries, has acquired a majority stake in Swedish company KeyPlants AB. The move will strengthen Masco’s leadership in engineering technologies for life sciences.
KeyPlants is a leading international industry partner for standardized as well as customized process-integrated modular prefabricated facility solutions. Based in Stockholm, the company has a fully integrated supply chain with more than 45 years of experience in project engineering, production and delivery, and has supplied more than 3,500 high-specification modules to at least 30 countries.
This partnership will strengthen Masco Group by combining its leadership in clean utilities and process technologies with KeyPlants’ expertise and innovative energy in prefabricated, modular facility solutions. It will support stronger value propositions for global supply chain challenges such as flexibility, reliability and fast-track manufacturing timelines to a global customer base of biopharmaceutical manufacturers and CDMOs focused on biologics, pharma and advanced therapy medicinal products (ATMPs), such as cell and gene therapies.
“We are extremely happy to partner with KeyPlants, as it will expand our capabilities, service and product offerings, and evolve our manufacturing capacity,” says Luca Borella, CEO of Masco Group. “We look forward to working with them to further accelerate the global adoption of their innovative fast-track facility solutions, which are an essential aspect in the life science industry.” He adds: “The companies share similar values, notably the commitment to teamwork, sustainability and customer care. Innovation is also an important synergetic element.”
“KeyPlants’ management and team are fully committed to this partnership with Masco Group,” says Jörgen Harrysson, Managing Director and Board Member of KeyPlants AB. “Its global presence and network enables KeyPlants to continue with our strategy to serve existing and new clients with our fast-track solutions, including customized facilities as well as standardized PODs. We are also thrilled to be able to expand our presence and offerings in North America, Europe and Africa.”
“We see KeyPlants and Masco Group as a perfect fit, and we are excited at the prospect of making KeyPlants and its skilled teams an integral part of the growth trajectory of the Masco Group family,” comments Frans K. A. Maas, Masco Group Board Member. “Masco Group is part of RSBG SE, a German-based long-term industrial partner of successful medium-sized companies, pursuing a buy-and-build strategy and focusing on competences and areas which are of great importance during global transformations. This acquisition supports the vision to become a technology-leading turnkey provider, in particular in the growing and demanding markets of biologics, vaccines and ATMPs.”
About Masco Group
Masco Group is an integrated solutions provider, partner to the top tier pharmaceutical and biotechnological companies. Its companies Stilmas, Olsa, DOC and BCD are leaders in clean utilities, process technologies and services. Headquartered in Milan-Italy, Masco Group has production sites and subsidiaries in Europe, America and Asia and serves more than 6000 clients globally, delivering around 300 projects per year.
More info: Masco Group
KeyPlants, headquartered in Stockholm, Sweden, is a leader in modular off-site construction for the life science industry, having delivered 100+ projects globally. Our customers benefit from KeyPlants’ vast experience and expertise, resulting in 30-50% shorter timelines and increased predictability with regards to schedule, cost, and quality. KeyPlants delivers turnkey facilities, including process equipment, utilities, and digital solutions.
More info: KeyPlants
In 2018 Stilmas Americas was acquired by Stilmas and became part of our family.
It’s been three whole years since then, a lot of things have changed, but our shared values and teamwork have only grown stronger. Here’s a few things you may not know about our production and commercial facility serving North America.
The last year was tough for all of us, so this fall we are particularly happy to be able to participate to the first live event in months!
The 2021 ISPE Annual Meeting & Expo focuses on agility, collaboration and innovation, three concepts that Stilmas has always had at heart, and even more in these latest difficult times, when the ability to be flexible, to adapt to new situations and to share solutions with others has been fundamental.
Come meet Stilmas and our North American branch and production facility Stilmas Americas at booth 722.
31 Oct – 3 Nov 2021
Hynes Convention Center, Boston, MA, USA or Virtual
You can find the official statement by Masco Group on Coronavirus here.
Masco Group and Stilmas have been on the front line in the fight against the pandemic, never stopping working on our products, which are essential to the pharmaceutical industry. We supplied systems for the production of therapeutics used against Covid-19, such as antivirals, vaccines and antibodies.At our facilities around the world we have put in place all suitable protection measures, both for our employees and our clients.
Since traveling is difficult, we are promoting for our clients the use of technologies such as smart glasses and virtual reality for the testing and maintenance of our systems.
Attention: due to the Coronavirus pandemic all the following events have been posponed or cancelled. More information will be released as the situation evolves.
Find out what trade fairs, conferences, exhibitions and events we are participating in this year and don’t miss the opportunities to get to know us and our capabilities better.
|ISPE EUROPE ANNUAL MEETING AND EXPO
31 March – 2 April 2020
7 – 13 May 2020
Sao Paulo (Brasil)
2 – 4 June 2020
1 – 3 October 2020
13 – 15 October 2020
|ISPE ANNUAL MEETING AND EXPO
1 – 4 November 2020
|Pharmtech & Ingredients
10 – 13 November 2020
New Delhi (India)
25 – 27 November 2020
Stilmas and Stilmas Russia will be present at Pharmtech & Ingredients 2019, Hall 8, Stand В6023.
21ST INTERNATIONAL EXHIBITION OF EQUIPMENT, RAW MATERIALS AND TECHNOLOGIES FOR PHARMACEUTICAL PRODUCTION
Pharmtech & Ingredients is the largest international exhibition in Russia and the EEU presenting equipment, raw materials and technologies for manufacturing pharmaceutical products, nutritional supplements, blood products and cosmetics.
Only at Pharmtech & Ingredients do exhibitors present a wide range of production and packaging equipment, laboratory equipment, technological solutions for creating turn-key pharmaceutical products, clinical trials, clean rooms, and pharmaceutical logistics. Visitors can see the majority of products in action at the exhibition, meet leading companies, consult them on solutions for their business, learn about the latest industry developments, and network with other professionals.
Pharmtech & Ingredients — это событие, которое собирает всех технологических лидеров отрасли и посетителей, заинтересованных в выборе оборудования, сырья и технологии для производства фармацевтических препаратов, БАДов, ветеринарных препаратов, препаратов крови и косметики.
Весь процесс производства, начиная от разработки проекта производства, закупки сырья, заканчивая упаковкой и транспортировкой готового изделия, демонстрируется на Pharmtech & Ingredients.
Stilmas Americas is attending the 2019 ISPE Annual Meeting and Expo in Las Vegas on 27-30 October.
This year’s meeting will focus on some relevant topics: modernization, globalization, and transformation in pharmaceutical science and manufacturing across the globe.
It is with great pleasure and honor that we announce that Masco Group has signed the acquisition of a majority shareholding of BCD Engineering Ltd, active since 1983 in the engineering and manufacturing of high purity process systems worldwide for the Pharmaceutical, Biotechnology, Food & Beverage and Chemical industries. They have particular expertise in Product Formulation, Clean in Place, Clean Utilities and Thermal Treatment technologies. Based out of Charleville-Cork Ireland, BCD employs about 250 highly skilled people.
This acquisition, pending CCPC Ireland approval, will strengthen Masco Group’s leadership in both the segment for Olsa liquid process (Pharma plus Food & Beverage) technologies as well as for Stilmas clean utilities, liquid processing, super skids and turn-key manufacturing systems for the global markets.
For more on their expertise, capabilities and industries served visit www.bcd.ie
Il prossimo 21-22 novembre avrà luogo un training workshop in lingua italiana promosso da Stilmas e DOC Validation dal titolo “Pharmaceutical Water & Steam Systems: Current International Industry Practices, Technological Trends and Regulatory News”.
Che argomenti verranno trattati?
Il seminario tratterà in generale di acqua e vapore per uso farmaceutico, con una panoramica completa in base alle direttive europee (EDQM/EMA), statunitensi (FDA/USP) e cGMP internazionali (Anvisa, WHO, PIC/S, etc.) supportata dall’esperienza globale di Stilmas e DOC relativa all’ispezione degli impianti.
Gli argomenti trattati nell’ambito delle clean utilities saranno: requisiti normativi, attuali criteri di design come da GEP e nuove tendenze tecnologiche, life-cycle della validazione e manutenzione, monitoraggio e controllo dei sistemi.
Quanto sono attuali queste tematiche?
Il materiale del seminario è aggiornato ai Regulatory Requirements del 2019, in particolar modo a causa della nuova monografia EP per Acqua per Iniettabili rilasciata ad aprile 2017 e alla bozza di revisione dell’EU GMP Annex 1 (dicembre 2017).
A chi è indirizzato questo seminario?
Il workshop è indirizzato ai professionisti e manager delle Industrie Farmaceutiche coinvolti nelle applicazioni dei sistemi di produzione di acqua e vapore ad uso farmaceutico (sistemi di Qualità QA e QC, Regolamentazione e Validazione, Ingegneria, Manutenzione e Produzione (API e sistemi di dosaggio).
Per ulteriori informazioni scrivere a: email@example.com
Stilmas will take part in the annual event CPhI Worldwide 2019 in Frankfurt.
Find our experts in the PMEC area, hall 11, booth 110B71.
The world’s largest pharmaceutical exhibition, CPhI Worldwide houses six zones representing each stage of the pharmaceutical supply chain – from APIs, machinery and packaging to outsourcing and biopharmaceuticals. Uniting over 45,000 visiting attendees and 2,500 international exhibitors, CPhI Worldwide is the place to network and source cost-effective pharma solutions from all over the world – in just 3 days, under one roof.
See the official Event Guide Preview
Join Stilmas at the 5th edition of the APIC Arab Pharmaceutical Industry Congress 2019 organized by Akhnaton Trading & Representation on 8-9 October at the Hilton Heliopolis in Cairo, Egypt.
Our experts will give lectures on thermocompression and Sustainability (focus on advances in critical utilities generation).
To register: https://bit.ly/2nbVP9A
The APIC is designed to provide an innovative and comprehensive overview of the latest developments in pharmaceutical industry. The event offers a platform for professionals to share knowledge, network, and discuss trends in the pharmaceutical industry with the pioneers in the field.
The three main streams (Scientific Lectures) will be: – Production, Bio pharmaceuticals & productivity. Quality assurance & Regulation Compliance. Research & Development.